"Our model portfolios are based on selecting stocks that meet the investing criteria of "legendary" investors," explains John Reese.

The editor of Validea continues, "Sanofi-Aventis (SNY), which is involved in pharmaceuticals and human vaccines, earns a Guru Score of 100% based on the value investing strategy of Benjamin Graham.

"In its pharmaceutical activity, the company specializes in six therapeutic areas: diabetes, oncology, thrombosis and cardiovascular, central nervous system (CNS), and internal medicine.

"We discriminate among investments primarily by their relative valuation metrics; we buy only those stocks we find undervalued relative to their own trading history, their peers or that of the market in general," says value investor John Buckingham.

The editor of The Prudent Speculator explains, "Two such buys are Marathon Oil (MRO) and Tsakos Energy Navigation (TNP).

"Both stocks could be chosen as part of the foundation of a portfolio for new investors or for those seeking to diversify their holdings.

"Among our latest buy recommendations -- based on the value investing strategy of Ben Graham -- we like Gilead Sciences (GILD) and Teva Pharmaceutical (TEVA)," says J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "Gilead is a biopharmaceutical company that discovers, develops and markets therapeutic treatments to combat viral, bacterial and fungal infections. Its shares undervalued at 9.7 times forward 12-month EPS.

"Teva, based in Israel, develops, makes and sells generic and proprietary-branded (store brand) drugs. Its shares are clearly undervalued at 10.6 times forward EPS. We consider both stocks to be very low risk.

Yesterday I began a review of the five major U.S. defense contractors, searching for potential stock value. The group included General Dynamics (GD), Lockheed Martin (LMT), Boeing (BA), Northrop, Grumman (NOC) and Raytheon (RTN). After examining the P/E, PEG, P/CF, P/S, and P/B, Boeing did not make it through the screens.

Today I continue the exercise, hoping to find a stock worthy of placing a bet.

Dividend Yield

• Lockheed Martin: 3.77%
• Raytheon Company: 3.16%
• Northrop, Grumman: 2.89%
• General Dynamics: 2.59%

The defense sector is down, but don't count it out. We give lip service to the likelihood of defense being a target of budget hawks in Congress, but truth be told, the same fiscally conservative members are often the biggest supporters of defense.

Equally important is that unlike many other industries, this is one tech sector that keeps most of its jobs at home and well-distributed through the country. This, too, preserves defense spending.

The major players in the industry after 20 years of consolidation are General Dynamics Corp (GD), Lockheed Martin (LMT), Boeing Co (BA), Northrop, Grumman (NOC), and Raytheon Company (RTN). In addition there are hundreds more making specialized parts in support of the majors and more still supplying basic elements like tires, wiring, computer processors, steel, aluminum, specialty glass, and ammunition. Then there are suppliers of manpower and smaller manufacturers producing unmanned aircraft drones and robots.

Never mind the drama in the front office, soap operas are not getting the ratings they used to. Let's take a closer look at the businesses and the stock metrics of Hewlett-Packard (HPQ) and Oracle Corp. (ORCL) that find themselves competing more and more each day. Mark Hurd, fired from HP and just recently installed as president of Oracle, has done nothing yet.

What do the numbers indicate?

"Benjamin Graham has been recognized for decades as the father of value investing; Warren Buffett is known as the Oracle of Omaha for his superior investing skills," asserts J. Royden Ward, adding, "For this report, we combine Warren Buffett's and Ben Graham's criteria for choosing stocks.

The advisor reviews Abbott Laboratories (ABT), Coach (COH), Intel (INTC), Mastercard (MA), Microsoft (MSFT) and Tupperware Brands (TUP).

Having accepted a speaking engagement at a university school of business recently, I had to think about what introductory information I could impart to the students about investing that would be practical, immediately useful and establish a foundation for whatever direction their paths might lead. This was supposed to be the first in a series. However, since I pull no punches and can be a little edgy in my candor and presentation, who knew if I would be invited back?

My outline had five basic elements. The first thing I told them was to start now!

I have always felt that for all the blabbing we do -- or blogging, in my case -- we should try as best we can to be accountable for our good and bad calls. This report is long overdue, but I will post it anyway since all of my past year's picks and results have been made public.

The market was very harsh in the early part of 2009, filling investors fear and trepidation, and sinking to a March 9, 2009 bottom. Perhaps some of the bleeding has stopped, but the economy has not healed as bears and bulls seem to carry the day, or every other day.

"Two newcomers to our recommended list come from a sector still dogged by fears -- the financial sector; and interestingly, both specialize in a bit of an unusual type of finance: pawn loans," says John Reese.

Here, the editor of Validea -- which focuses on stocks that meet the investment criteria of some of the market's most successful professional investors -- offers a bullish review of EZCorp (EZPW) and Cash America International (CSH).

"Cash America gets approval from my James O'Shaughnessy-based strategy -- as well as from my Benjamin Graham value investing model.

Over the past four years I have made numerous bad calls. Thankfully, I have made far more good calls. But if only I would have been right all the time, then I would probably have a lot more of your money. To bet and never lose adds up pretty quickly to a substantial bit of change.

Yesterday when I posted Chasing Value: Citigroup Beats Apple one commenter took me to task "Didn't you post the same post about Berkshire B versus Apple at the beginning of the year?" The answer is yes, and I stand by that belief.

These two great companies, Apple Inc. (AAPL) and Berkshire Hathaway (BRK.B) led by extremely talented entrepreneurs, have very divergent businesses, by design, and neither would choose any other path. I could not help but go back to examine the stock records for the year to see by how far I might have blundered, assuming our reader already had. Here is what I found.

"Loews Corp. (L) is a holding company run by the New York Tisch family; the stock is selling at less than nine times earnings, and an almost 30% discount to its NAV, based on a sum of the parts," says Adrian Day.

The money manager and editor of The Global Analyst explains, "The company's businesses are mostly doing well; the balance sheet is rock solid; and the shares are undervalued.

"In our newsletter, we maintain numerous model portfolios based on the strategies of leading investors, such as Warren Buffett, Ben Graham and Peter Lynch," explains John Reese.

The editor of Validea asserts, "Our Kenneth Fisher-based Portfolio has shown a 7-year annualized return of 11.9%; this approach focuses on a metric Fisher pioneered: the price/sales ratio.

"While investors for decades relied heavily on the P/E ratio, Fisher found that earnings -- even the earnings of good companies -- can fluctuate greatly from year to year.

"While others will focus on the fear, we will continue to focus on the facts and figures; and right now, they show that there are plenty of good values out there," says John Reese.

The editor of Validea explains, "The market often turns when things look bleakest, and fear is running rampant. That's what so many of the gurus I follow knew. David Dreman has written extensively about buying unloved stocks, or being bullish in times of outright crisis.

"Warren Buffett has said that the time to be greedy is when others are fearful. And Peter Lynch has said having the stomach to stay disciplined during emotional times is critical to making money in stocks.

"Following a record low reading for new home sales, you might think now is the worst time to bet on a housing recovery," says Lou Basenese.

The editor of the Small Cap and Special Situations Report asserts, "Think again. The aftermath of such disappointing news represents an ideal contrarian opportunity.

And one such opportunity is Avatar Holdings (AVTR), which ranks as a buy even by Ben Graham's strict value criteria.